Sutro Biopharma, Inc.

Abigail Yu

Ryan Stafford

Alice Yam

Xiaofan Li

Gang Yin

Cristina Abrahams

Krishna Bajjuri

Daniel Calarese

Andreas Maderna

Jeffrey Hanson

Amandeep Gakhal

Miao Wen

Helena Kiefel

Kristin Bedard

Junhao Yang

Stephanie Armstrong

The present disclosure relates to antibodies and antibody conjugates, for instance antibody drug conjugates, with binding specificity for receptor tyrosine kinase orphan receptor 1 (ROR1) and its isoforms and homologs, and compositions comprising the antibodies or antibody conjugates, including pharmaceutical compositions. Also provided are methods of producing the antibodies and antibody conjugates and compositions thereof as well as methods of using the antibodies and antibody conjugates and compositions thereof, such as in therapeutic and diagnostic methods.

Anti-ROR1 antibody conjugates, compositions comprising anti ROR1 antibody conjugates, and methods of making and using anti-ROR1 antibody conjugates preliminary class

Anti-ROR1 antibody conjugates, compositions comprising anti ROR1 antibody conjugates, and methods of making and using anti-ROR1 antibody conjugates

The present disclosure relates to antibodies that selectively bind to B-cell maturation antigen (BCMA) and its isoforms and homologs, and compositions comprising the antibodies. Also provided are methods of using the antibodies, such as therapeutic and diagnostic methods.

Anti-BCMA antibodies and treatment methods

Growing community of inventors

San Jose, CA, United States of America

Abigail Yu